Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0584
-0.0006 (-1.02%)
Jan 23, 2026, 3:28 PM EST
PVCT Market Cap
PVCT has a market cap or net worth of $24.54 million as of January 23, 2026. Its market cap has decreased by -51.33% in one year.
Market Cap
24.54M
Enterprise Value
26.91M
Revenue
350.44K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 24.54M, an increase of 567,793.22%. That is a compound annual growth rate of 43.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 24.68M | 5.04% |
| Dec 31, 2025 | 23.49M | -53.46% |
| Dec 31, 2024 | 50.48M | 25.33% |
| Dec 29, 2023 | 40.27M | -11.35% |
| Dec 30, 2022 | 45.43M | 96.93% |
| Dec 31, 2021 | 23.07M | -1.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LakeShore Biopharma | 34.82M |
| ZIVO Bioscience | 33.98M |
| Harvard Apparatus Regenerative Technology | 25.49M |
| EOM Pharmaceuticals Holdings | 24.54M |
| Finch Therapeutics Group | 23.12M |
| Zeo ScientifiX | 18.01M |
| Ayala Pharmaceuticals | 14.83M |
| TRON Group | 13.86M |